The Gastrointestinal Safety of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
This places it among the more expensive options for weight management
This includes awareness of personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and consideration of diabetic retinopathy status, as additional monitoring may be required if you have pre-existing retinopathy
The impact of GLP-1 drugs on bariatric surgery (weight loss surgery) is an example of the latter - competition that snuck up quietly but then manifested severely and rapidly
Stable Gastric Pentadecapeptide BPC 157, Roberts Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selyes Stress Coping Response: Progress, Achievements, and the Future. Gut and liver vol